Study of an experimental drug for diabetic macular edema
Part of Eyes & vision clinical trials.
This trial tests an investigational drug called CU06-1004 for people with diabetic macular edema (swelling in the center of the retina caused by diabetes). It aims to see if the drug can improve vision and reduce swelling.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older and have type 1 or type 2 diabetes.
- You must have diabetic macular edema causing thickening in the center of your retina in at least one eye.
- Your vision in the study eye must be between 20/50 and 20/320 on a standard eye chart.
- You must be willing to use reliable birth control if needed.
- You cannot have certain other eye conditions or recent treatments that might interfere with the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new eye drop or injection called ENN0403 for people with diabetic macular edema (swelling in the back of the eye due to diabetes). The goal is to see if it can improve vision and reduce swelling.
This Phase 1 study tests the safety and early effectiveness of OCU200 eye injections in people with diabetic macular edema (DME) that affects the center of vision. It may help by reducing the eye swelling that blurs vision from diabetes.
This trial tests whether a substance called tauroursodeoxycholate (TUDCA) or a traditional Chinese medicine can help reduce swelling in the back of the eye caused by diabetes. It is for people with diabetic retinopathy and diabetic macular edema who have not had recent eye surgeries or changes in blood sugar or blood pressure control.
This early-phase trial tests a new implant (EC-104) that goes inside the eye to treat diabetic macular edema (DME), a condition that causes blurry vision from fluid buildup. The implant slowly releases medicine over time, and the study will see if it is safe and helpful for people with DME.
This study tests different doses of a new medicine (BI 3812465) injected into the eye to treat diabetic macular edema—swelling in the back of the eye caused by diabetes that can blur vision. The trial measures how safe the medicine is and how well patients tolerate it.
This study compares two injectable medicines (BAT5906 and Lucentis) to treat diabetic macular edema—swelling in the back of the eye that blurs vision. Both drugs block a protein that causes abnormal blood vessel leakage, and this trial will show which works better.
Hear when a new Diabetic Macular Edema trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.